Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh

S. S. Rahman, S. Jabeen, M. Malakar, J. Khatoon, N. Ahmed, S. M. Chowdhury, S. E. Holck, B. Busca, Halida Akhter

Research output: Contribution to journalArticle

Abstract

In preparation for introducing the injectable contraceptive norethisterone enantate (NET-EN) into the national family planning programme, a field study was conducted in six family planning clinics in Bangladesh. A total of 913 women elected to receive injections of NET-EN every 8 weeks for 6 months and every 12 weeks thereafter. At 12 months of follow-up, the overall discontinuation rate was 37.3 per 100 women, the most common reason for discontinuation being bleeding disturbances. Marked differences in continuation rates in different centres pointed out the need for further research into clinic characteristics that may affect acceptance and continuation rates. Problems encountered during the study helped to pinpoint service delivery issues that need to be considered when introducing NET-EN into a family planning programme, including the need for thorough training of all clinic staff, adequate supplies of NET-EN, and provision of alternative methods of contraception for women who may not be able to return for the next scheduled visit.

Original languageEnglish (US)
Pages (from-to)785-791
Number of pages7
JournalBulletin of the World Health Organization
Volume63
Issue number4
StatePublished - Dec 1 1985
Externally publishedYes

Fingerprint

Norethindrone
Bangladesh
Family Planning Services
Contraceptive Agents
Injections
Contraception
Hemorrhage
Research

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Rahman, S. S., Jabeen, S., Malakar, M., Khatoon, J., Ahmed, N., Chowdhury, S. M., ... Akhter, H. (1985). Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh. Bulletin of the World Health Organization, 63(4), 785-791.

Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh. / Rahman, S. S.; Jabeen, S.; Malakar, M.; Khatoon, J.; Ahmed, N.; Chowdhury, S. M.; Holck, S. E.; Busca, B.; Akhter, Halida.

In: Bulletin of the World Health Organization, Vol. 63, No. 4, 01.12.1985, p. 785-791.

Research output: Contribution to journalArticle

Rahman, SS, Jabeen, S, Malakar, M, Khatoon, J, Ahmed, N, Chowdhury, SM, Holck, SE, Busca, B & Akhter, H 1985, 'Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh', Bulletin of the World Health Organization, vol. 63, no. 4, pp. 785-791.
Rahman SS, Jabeen S, Malakar M, Khatoon J, Ahmed N, Chowdhury SM et al. Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh. Bulletin of the World Health Organization. 1985 Dec 1;63(4):785-791.
Rahman, S. S. ; Jabeen, S. ; Malakar, M. ; Khatoon, J. ; Ahmed, N. ; Chowdhury, S. M. ; Holck, S. E. ; Busca, B. ; Akhter, Halida. / Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh. In: Bulletin of the World Health Organization. 1985 ; Vol. 63, No. 4. pp. 785-791.
@article{bfa2d0da2b594090b0e901a32da74330,
title = "Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh",
abstract = "In preparation for introducing the injectable contraceptive norethisterone enantate (NET-EN) into the national family planning programme, a field study was conducted in six family planning clinics in Bangladesh. A total of 913 women elected to receive injections of NET-EN every 8 weeks for 6 months and every 12 weeks thereafter. At 12 months of follow-up, the overall discontinuation rate was 37.3 per 100 women, the most common reason for discontinuation being bleeding disturbances. Marked differences in continuation rates in different centres pointed out the need for further research into clinic characteristics that may affect acceptance and continuation rates. Problems encountered during the study helped to pinpoint service delivery issues that need to be considered when introducing NET-EN into a family planning programme, including the need for thorough training of all clinic staff, adequate supplies of NET-EN, and provision of alternative methods of contraception for women who may not be able to return for the next scheduled visit.",
author = "Rahman, {S. S.} and S. Jabeen and M. Malakar and J. Khatoon and N. Ahmed and Chowdhury, {S. M.} and Holck, {S. E.} and B. Busca and Halida Akhter",
year = "1985",
month = "12",
day = "1",
language = "English (US)",
volume = "63",
pages = "785--791",
journal = "Bulletin of the World Health Organization",
issn = "0042-9686",
publisher = "World Health Organization",
number = "4",

}

TY - JOUR

T1 - Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh

AU - Rahman, S. S.

AU - Jabeen, S.

AU - Malakar, M.

AU - Khatoon, J.

AU - Ahmed, N.

AU - Chowdhury, S. M.

AU - Holck, S. E.

AU - Busca, B.

AU - Akhter, Halida

PY - 1985/12/1

Y1 - 1985/12/1

N2 - In preparation for introducing the injectable contraceptive norethisterone enantate (NET-EN) into the national family planning programme, a field study was conducted in six family planning clinics in Bangladesh. A total of 913 women elected to receive injections of NET-EN every 8 weeks for 6 months and every 12 weeks thereafter. At 12 months of follow-up, the overall discontinuation rate was 37.3 per 100 women, the most common reason for discontinuation being bleeding disturbances. Marked differences in continuation rates in different centres pointed out the need for further research into clinic characteristics that may affect acceptance and continuation rates. Problems encountered during the study helped to pinpoint service delivery issues that need to be considered when introducing NET-EN into a family planning programme, including the need for thorough training of all clinic staff, adequate supplies of NET-EN, and provision of alternative methods of contraception for women who may not be able to return for the next scheduled visit.

AB - In preparation for introducing the injectable contraceptive norethisterone enantate (NET-EN) into the national family planning programme, a field study was conducted in six family planning clinics in Bangladesh. A total of 913 women elected to receive injections of NET-EN every 8 weeks for 6 months and every 12 weeks thereafter. At 12 months of follow-up, the overall discontinuation rate was 37.3 per 100 women, the most common reason for discontinuation being bleeding disturbances. Marked differences in continuation rates in different centres pointed out the need for further research into clinic characteristics that may affect acceptance and continuation rates. Problems encountered during the study helped to pinpoint service delivery issues that need to be considered when introducing NET-EN into a family planning programme, including the need for thorough training of all clinic staff, adequate supplies of NET-EN, and provision of alternative methods of contraception for women who may not be able to return for the next scheduled visit.

UR - http://www.scopus.com/inward/record.url?scp=0022352439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022352439&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 785

EP - 791

JO - Bulletin of the World Health Organization

JF - Bulletin of the World Health Organization

SN - 0042-9686

IS - 4

ER -